TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study

[1]  G. Hoxhaj,et al.  The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism , 2019, Nature Reviews Cancer.

[2]  D. Kwiatkowski,et al.  Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex. , 2019, Annual review of genomics and human genetics.

[3]  D. Kwiatkowski,et al.  A diagnostic algorithm for enhanced detection of mosaic tuberous sclerosis complex in adults , 2019, The British journal of dermatology.

[4]  B. Scherrer,et al.  Tuberous Sclerosis Complex Genotypes and Developmental Phenotype. , 2019, Pediatric neurology.

[5]  A. Thorner,et al.  Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission , 2019, Genetics in Medicine.

[6]  D. Kwiatkowski,et al.  Phenotypic distinctions between mosaic forms of tuberous sclerosis complex , 2019, Genetics in Medicine.

[7]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[8]  E. Thiele,et al.  Tuberous Sclerosis Complex , 2019, Harper's Textbook of Pediatric Dermatology.

[9]  Ling Lin,et al.  Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing , 2015, PLoS genetics.

[10]  D. Kwiatkowski,et al.  Molecular basis of giant cells in tuberous sclerosis complex. , 2014, The New England journal of medicine.

[11]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[12]  Hugo J. Kuijf,et al.  Image processing techniques for quantification and assessment of brain MRI , 2013 .

[13]  Hope Northrup,et al.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. , 2013, Pediatric neurology.

[14]  D. Kwiatkowski,et al.  Genotype and cognitive phenotype of patients with tuberous sclerosis complex , 2011, European Journal of Human Genetics.

[15]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[16]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[17]  A. Algra,et al.  Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations , 2008, Neurology.

[18]  J. Wheless,et al.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States , 2007, Genetics in Medicine.

[19]  A. Ouweland,et al.  Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex , 2005, European Journal of Human Genetics.

[20]  D. Kwiatkowski,et al.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. , 2001, American journal of human genetics.

[21]  S. Verhoef,et al.  High rate of mosaicism in tuberous sclerosis complex. , 1999, American journal of human genetics.

[22]  J. Maynard,et al.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. , 1999, American journal of human genetics.

[23]  H. Northrup,et al.  Germ-line mosaicism in tuberous sclerosis: how common? , 1999, American journal of human genetics.

[24]  D. Kwiatkowski,et al.  Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. , 1999, The New England journal of medicine.